Nitrite activates protein kinase A in normoxia to mediate mitochondrial fusion and tolerance to ischaemia/reperfusion

Cardiovascular Research

Volumn 101, Issue 1, 2014, Pages 57-68

  Pride, Christelle Kamga ^a   Mo, Li ^a   Quesnelle, Kelly ^a   Dagda, Ruben K ^b   Murillo, Daniel ^a   Geary, Lisa ^a   Corey, Catherine ^a   Portella, Rafael ^a   Zharikov, Sergey ^a   St Croix, Claudette ^a   Maniar, Salony ^a   Chu, Charleen T ^b   K H Khoo, Nicholas ^b   Shiva, Sruti ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Ischaemia; Mitochondria; Nitrite nitrate; Pre conditioning; Protein kinase A

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; DYNAMIN RELATED PROTEIN 1; NITRITE; REACTIVE OXYGEN METABOLITE; REGULATOR PROTEIN; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL HYPOXIA; CELL ISOLATION; CELL PROTECTION; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART MUSCLE CELL; HEART PROTECTION; IMMUNOFLUORESCENCE MICROSCOPY; ISCHEMIA; MALE; MITOCHONDRIAL FUSION; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN TARGETING; RAT; REPERFUSION INJURY;

ISCHAEMIA; MITOCHONDRIA; NITRITE/NITRATE; PRE-CONDITIONING; PROTEIN KINASE A;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANOXIA; CELL LINE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYTOPROTECTION; DYNAMINS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MITOCHONDRIAL DYNAMICS; NITRITES; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDES;

EID: 84891366915     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt224     Document Type: Article

References (63)

1. Duranski MR, Greer JJ, Dejam A, Jaganmohan S, Hogg N, LangstonWet al. Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest 2005;115:1232-1240.
2. Tripatara P, Patel NS,Webb A, Rathod K, Lecomte FM, Mazzon E et al. Nitrite-derived nitric oxide protects the rat kidney against ischemia/reperfusion injury in vivo: role for xanthine oxidoreductase. J Am Soc Nephrol 2007;18:570-580.
3. Jung KH,Chu K,KoSY, Lee ST, Sinn DI, ParkDKet al. Early intravenous infusion of sodium nitrite protects brain against in vivo ischemia-reperfusion injury. Stroke 2006;37: 2744-2750.
4. Dezfulian C, Raat N, Shiva S, Gladwin MT. Role of the anion nitrite in ischemia-reperfusion cytoprotection and therapeutics. Cardiovasc Res 2007;75:327-338.
5. Webb A, Bond R, McLean P, Uppal R, Benjamin N, Ahluwalia A. Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage. Proc Natl Acad Sci USA 2004;101:13683-13688.
6. Kumar D, Branch BG, Pattillo CB, Hood J, Thoma S, Simpson S et al. Chronic sodium nitrite therapy augments ischemia-induced angiogenesis and arteriogenesis. Proc Natl Acad Sci USA 2008;105:7540-7545.
7. Lundberg JO, Weitzberg E, Gladwin MT. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 2008;7:156-167.
8. Gonzalez FM, Shiva S, Vincent PS, Ringwood LA, Hsu LY, Hon YY et al. Nitrite anion provides potent cytoprotective and antiapoptotic effects as adjunctive therapy to reperfusion for acute myocardial infarction. Circulation 2008;117:2986-2994.
9. Bryan NS, Calvert JW, Elrod JW, Gundewar S, Ji SY, Lefer DJ. Dietary nitrite supplementation protects against myocardial ischemia-reperfusion injury. Proc Natl Acad Sci USA 2007;104:19144-19149.
10. Hendgen-Cotta UB, MerxMW, Shiva S, Schmitz J, Becher S, Klare JP et al. Nitrite reductase activity of myoglobin regulates respiration and cellular viability in myocardial ischemia-reperfusion injury. Proc Natl Acad Sci USA 2008;105:10256-10261.
11. Shiva S, Huang Z, Grubina R, Sun J, Ringwood LA, MacArthur PH et al. Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration. Circ Res 2007;100:654-661.
12. Rassaf T, Flogel U, Drexhage C, Hendgen-Cotta U, Kelm M, Schrader J. Nitrite reductase function of deoxymyoglobin: oxygen sensor and regulator of cardiac energetics and function. Circ Res 2007;100:1749-1754.
13. Li H, Samouilov A, Liu X, Zweier JL. Characterization of the magnitude and kinetics of xanthine oxidase-catalyzed nitrite reduction. Evaluation of its role in nitric oxide generation in anoxic tissues. J Biol Chem 2001;276:24482-24489.
14. Shiva S, Sack MN, Greer JJ, Duranski M, Ringwood LA, Burwell L et al. Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J Exp Med 2007;204:2089-2102.
15. Raat NJ, NoguchiAC, Liu VB, Raghavachari N, Liu D,XuXet al. Dietary nitrate and nitrite modulate blood and organ nitrite and the cellular ischemic stress response. Free Radic Biol Med 2009;47:510-517.
16. Ong SB, Subrayan S, Lim SY, Yellon DM, Davidson SM, Hausenloy DJ. Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation 2010;121:2012-2022.
17. Steenbergen C, Das S, Su J,Wong R, Murphy E. Cardioprotection and altered mitochondrial adenine nucleotide transport. Basic Res Cardiol 2009;104:149-156.
18. Stowe DF, Kevin LG. Cardiac preconditioning by volatile anesthetic agents: a defining role for altered mitochondrial bioenergetics. Antioxid Redox Signal 2004;6:439-448.
19. Donato M, Gelpi RJ. Adenosine and cardioprotection during reperfusion-an overview. Mol Cell Biochem 2003;251:153-159.
20. Vanden Hoek TL, Becker LB, Shao Z, Li C, Schumacker PT. Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J Biol Chem 1998;273:18092-18098.
21. Zmijewski JW, Banerjee S, Bae H, Friggeri A, Lazarowski ER, Abraham E. Exposure to hydrogen peroxide induces oxidation and activation of AMP-activated protein kinase. J Biol Chem 2010;285:33154-33164.
22. Schumacker PT. Lung cell hypoxia: role of mitochondrial reactive oxygen species signaling in triggering responses. Proc Am Thorac Soc 2011;8:477-484.
23. Kim H, Scimia MC, Wilkinson D, Trelles RD,Wood MR, Bowtell D et al. Fine-tuning of Drp1/Fis1 availability by AKAP121/Siah2 regulates mitochondrial adaptation to hypoxia. Mol Cell 2011;44:532-544.
24. Dickey AS, Strack S. PKA/AKAP1 and PP2A/Bbeta2 regulate neuronal morphogenesis via Drp1 phosphorylation and mitochondrial bioenergetics. J Neurosci 2011;31: 15716-15726.
25. Esumi K, Nishida M, Shaw D, Smith TW, Marsh JD. NADH measurements in adult rat myocytes during simulated ischemia. Am J Physiol 1991;260:H1743-H1752.
26. Lecour S, Suleman N, Deuchar GA, Somers S, Lacerda L, Huisamen B et al. Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase). Circulation 2005;112:3911-3918.
27. Stephanou A, Brar BK, Scarabelli TM, Jonassen AK, Yellon DM, Marber MS et al. Ischemia-induced STAT-1 expression and activation play a critical role in cardiomyocyte apoptosis. J Biol Chem 2000;275:10002-10008.
28. Suleman N, Somers S, Smith R, Opie LH, Lecour SC. Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning. Cardiovasc Res 2008;79: 127-133.
29. MoL,Wang Y, Geary L, CoreyC, Alef MJ, Beer-StolzDet al. Nitrite activatesAMPkinase to stimulate mitochondrial biogenesis independent of soluble guanylate cyclase. Free Radic Biol Med 2012;53:1440-1450.
30. Gardner PR, Nguyen DD, White CW. Aconitase is a sensitive and critical target of oxygen poisoning in cultured mammalian cells and in rat lungs. Proc Natl Acad Sci USA 1994;91:12248-12252.
31. Khoo NK, White CR, Pozzo-Miller L, Zhou F, Constance C, Inoue Tet al. Dietary flavonoid quercetin stimulates vasorelaxation in aortic vessels. Free Radic Biol Med 2010;49: 339-347.
32. Cribbs JT, Strack S. Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death. EMBO Rep 2007;8:939-944.
33. Wang X, Kettenhofen NJ, Shiva S, Hogg N, Gladwin MT. Copper dependence of the biotin switch assay: modified assay for measuring cellular and blood nitrosated proteins. Free Radic Biol Med 2008;44:1362-1372.
34. Curtis E, Hsu LL, Noguchi AC, Geary L, Shiva S. Oxygen regulates tissue nitrite metabolism. Antioxid Redox Signal 2012;17:951-961.
35. Hausenloy D, Wynne A, Duchen M, Yellon D. Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection. Circulation 2004;109:1714-1717.
36. Dagda RK, Gusdon AM, Pien I, Strack S, Green S, LiCet al. Mitochondrially localized PKA reverses mitochondrial pathology and dysfunction in a cellular model of Parkinson's disease. Cell Death Differ 2011;18:1914-1923.
37. Bolli R. The late phase of preconditioning. Circ Res 2000;87:972-983.
38. Jennings RB, Murry CE, Reimer KA. Preconditioning myocardium with ischemia. Cardiovasc Drugs Ther 1991;5:933-938.
39. Ong SB, Hausenloy DJ. Mitochondrial morphology and cardiovascular disease. Cardiovasc Res 2010;88:16-29.
40. Olichon A, Baricault L, Gas N, Guillou E, Valette A, Belenguer P et al. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J Biol Chem 2003;278:7743-7746.
41. Bach D, Pich S, Soriano FX, Vega N, Baumgartner B, Oriola J et al. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J Biol Chem 2003;278:17190-17197.
42. Pich S, Bach D, Briones P, Liesa M, Camps M, Testar X et al. The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system. Hum Mol Genet 2005;14:1405-1415.
43. Young LH. AMP-activated protein kinase conducts the ischemic stress response orchestra. Circulation 2008;117:832-840.
44. Paiva MA, Rutter-Locher Z, Goncalves LM, Providencia LA, Davidson SM, Yellon DM et al. Enhancing AMPK activation during ischemia protects the diabetic heart against reperfusion injury. Am J Physiol Heart Circ Physiol 2011;300:H2123-2134.
45. Pauly M, Daussin F, BurelleY, Li T, Godin R, Fauconnier J et al.AMPKactivation stimulates autophagy and ameliorates muscular dystrophy in the mdx mouse diaphragm.AmJ Pathol 2012;181:583-592.
46. Raat NJ, Shiva S, Gladwin MT. Effects of nitrite on modulating ROS generation following ischemia and reperfusion. Adv Drug Deliv Rev 2009;61:339-350.
47. van der Vliet A, Eiserich JP, Halliwell B, Cross CE. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity. J Biol Chem 1997;272:7617-7625.
48. Wang L, Frizzell SA, Zhao X, GladwinMT. Normoxic cyclicGMP-independent oxidative signaling by nitrite enhances airway epithelial cell proliferation and wound healing. Nitric Oxide 2012;26:203-210.
49. Coles B, BloodsworthA, Eiserich JP, Coffey MJ, McLoughlin RM, Giddings JC et al. Nitrolinoleate inhibits platelet activation by attenuating calcium mobilization and inducing phosphorylation of vasodilator-stimulated phosphoprotein through elevation of cAMP. J Biol Chem 2002;277:5832-5840.
50. Perlman DH, Bauer SM, Ashrafian H, Bryan NS, Garcia-Saura MF, Lim CC et al. Mechanistic insights into nitrite-induced cardioprotection using an integrated metabolomic/proteomic approach. Circ Res 2009;104:796-804.
51. Venkatesh PK, Pattillo CB, Branch B, Hood J, Thoma S, Illum S et al. Dipyridamole enhances ischaemia-induced arteriogenesis through an endocrine nitrite/nitric oxidedependent pathway. Cardiovasc Res 2010;85:661-670.
52. Giedt RJ, Yang C, Zweier JL, Matzavinos A, Alevriadou BR. Mitochondrial fission in endothelial cells after simulated ischemia/reperfusion: role of nitric oxide and reactive oxygen species. Free Radic Biol Med 2012;52:348-356.
53. Neuspiel M, Zunino R, Gangaraju S, Rippstein P, McBride H. Activated mitofusin 2 signals mitochondrial fusion, interferes with Bax activation, and reduces susceptibility to radical induced depolarization. J Biol Chem 2005;280:25060-25070.
54. Sukhodub A, Jovanovic S, Du Q, Budas G, Clelland AK, Shen M et al. AMP-activated protein kinase mediates preconditioning in cardiomyocytes by regulating activity and trafficking of sarcolemmalATP-sensitive K(+) channels. J Cell Physiol 2007;210:224-236.
55. Matsui Y, Kyoi S, Takagi H, Hsu CP, Hariharan N, Ago T et al. Molecular mechanisms and physiological significance of autophagy during myocardial ischemia and reperfusion. Autophagy 2008;4:409-415.
56. Matsui Y, Takagi H, Qu X, Abdellatif M, Sakoda H, Asano T et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circulation Res 2007;100:914-922.
57. Lee M, Hwang JT, Lee HJ, Jung SN, Kang I, Chi SG et al. AMP-activated protein kinase activity is critical for hypoxia-inducible factor-1 transcriptional activity and its target gene expression under hypoxic conditions in DU145 cells. J Biol Chem 2003;278: 39653-39661.
58. Jung SN, Yang WK, Kim J, Kim HS, Kim EJ, Yun H et al. Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells. Carcinogenesis 2008;29:713-721.
59. Lamberts RR, Onderwater G, Hamdani N, Vreden MJ, Steenhuisen J, Eringa EC et al. Reactive oxygen species-induced stimulation of 5?AMP-activated protein kinase mediates sevoflurane-induced cardioprotection. Circulation 2009;120:S10-15.
60. Cool B, Zinker B, ChiouW, Kifle L, Cao N, PerhamMet al. Identification and characterization of a small moleculeAMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab 2006;3:403-416.
61. Konishi M, Haraguchi G, Ohigashi H, Ishihara T, Saito K, Nakano Yet al. Adiponectin protects against doxorubicin-induced cardiomyopathy by anti-apoptotic effects through AMPK up-regulation. Cardiovasc Res 2011;89:309-319.
62. Zhu SG, Kukreja RC, Das A, Chen Q, Lesnefsky EJ, Xi L. Dietary nitrate supplementation protects against Doxorubicin-induced cardiomyopathy by improving mitochondrial function. J Am Coll Cardiol 2011;57:2181-2189.
63. Carlstrom M, Larsen FJ, Nystrom T, Hezel M, Borniquel S,Weitzberg E et al. Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitric oxide synthase-deficient mice. Proc Natl Acad Sci USA 2010;107:17716-17720.